State Street’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-188,676
Closed -$28.8K 4701
2023
Q2
$28.8K Hold
188,676
﹤0.01% 4538
2023
Q1
$27.1K Hold
188,676
﹤0.01% 4638
2022
Q4
$22.6K Sell
188,676
-26,800
-12% -$3.87K ﹤0.01% 4711
2022
Q3
$39K Sell
215,476
-166,200
-44% -$89.4K ﹤0.01% 4707
2022
Q2
$676K Sell
381,676
-865,246
-69% -$1.94M ﹤0.01% 3725
2022
Q1
$3.75M Buy
1,246,922
+300,345
+32% +$804K ﹤0.01% 3317
2021
Q4
$3.52M Sell
946,577
-7,854,914
-89% -$46M ﹤0.01% 3406
2021
Q3
$52.2M Buy
8,801,491
+5,829,894
+196% +$81.9M ﹤0.01% 1773
2021
Q2
$51.6M Sell
2,971,597
-119,140
-4% -$2.17M ﹤0.01% 1821
2021
Q1
$59M Buy
3,090,737
+3,063,237
+11,139% +$55.9M ﹤0.01% 1615
2020
Q4
$481K Buy
+27,500
New +$329K ﹤0.01% 3653

Other funds holding HGEN

State Street's HGEN Position: Q3 2023 in Review

State Street sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 188,676 shares — an estimated $28.8K sold.

State Street first reported a position in HGEN in Q4 2020 and held it in 11 quarters. The position peaked at $59M in Q1 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

  • State Street reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
  • State Street sold 188,676 HUMANIGEN, INC. shares in Q3 2023, an estimated $28.8K.
  • State Street first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 11 quarters.
  • State Street's HUMANIGEN, INC. position peaked at $59M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.